Preliminary phytochemical investigation on Mama powder — an approved herbal antimalarial in Nigeria
| dc.contributor.author | Ajayi, Clement Olusoji | |
| dc.contributor.author | Elujoba, Anthony A | |
| dc.contributor.author | Adepiti, Awodayo O | |
| dc.date.accessioned | 2024-03-07T12:26:53Z | |
| dc.date.available | 2024-03-07T12:26:53Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Malaria is an endemic disease in Africa where one out of four mortalities is reported regularly. Despite the discovery of artemisinin-combination therapy (ACT), high mortality rate persists due to chloroquine-resistant Plasmodium falciparum; hence, there is a need for new antimalarial drugs. A mixture of powdered Alstonia boonei De Wild (Apocynaceae) stem-bark (A) and powdered Picralima nitida (Stapf) T. Durand & H. Durand (Apocynaceae) seed (P), in the ratio 1:2 (Mama powder), is an FDA-approved herbal antimalarial in Nigeria. Hitherto, no phytochemical investigation on the mixture has been reported; hence, a preliminary phytochemical investigation is hereby communicated for the first time. | en_US |
| dc.identifier.citation | Clement Olusoji Ajayi et al. (2018), Preliminary phytochemical investigation on Mama powder — an approved herbal antimalarial in Nigeria.Am J Ethnomed | en_US |
| dc.identifier.uri | http://ir.must.ac.ug/handle/123456789/3464 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Am J Ethnomed | en_US |
| dc.subject | Malaria | en_US |
| dc.subject | Artemisinin-combination therapy | en_US |
| dc.title | Preliminary phytochemical investigation on Mama powder — an approved herbal antimalarial in Nigeria | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Preliminary phytochemical investigation on Mama powder- an approved herbal antimalarial in Nigeria.pdf
- Size:
- 240.46 KB
- Format:
- Adobe Portable Document Format
- Description:
- Conference paper
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: